{
    "2021-03-10": [
        [
            {
                "time": "",
                "original_text": "天坛生物(600161.SH)定增申请获中国证监会核准",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "定增",
                        "证监会",
                        "核准"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "2020年血制品批签发数据跟踪报告：整体批签发同比增长 白蛋白、静丙全年实现增量",
                "features": {
                    "keywords": [
                        "2020年",
                        "血制品",
                        "批签发",
                        "同比增长",
                        "白蛋白",
                        "静丙"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}